4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-119091
Chief Financial Officer sold 12,000 shares at $30.38 ($364,573)
- Chief Financial Officer acquired 12,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2023-11-14 | Option exercise | +12,000 | $6.88 | $82,560 | 73,406 | D: show line 1 in the form |
| Smith Hunter C Chief Financial Officer | 2023-11-14 | Sale | −12,000 | $30.38 | $364,573 | 61,406 | D: show line 2 in the form |
| Open-market sales · 12,000 sh · avg $30.38 · $364,573 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Hunter C Chief Financial Officer | 2023-11-14 | Option exercise · Stock Option (Right to Buy) | −12,000 | 149,094 | D: show line 3 in the form |
Loading xslF345X05/tm2330902-1_4seq1.xml…